Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2021 ) > List of Articles

CASE REPORT

Effectiveness of Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Manivel Arumugam, Senthil Dhanasekaran, Kancherla Roopa, Pitchaimani Govindharaj

Keywords : Hormonal therapy, lymphangioleiomyomatosis, pulmonary rehabilitation

Citation Information : Arumugam M, Dhanasekaran S, Roopa K, Govindharaj P. Effectiveness of Pulmonary Rehabilitation in Lymphangioleiomyomatosis. Indian J Respir Care 2021; 10 (2):252-256.

DOI: 10.4103/ijrc.ijrc_94_20

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2021; Indian Journal of Respiratory Care.


Abstract

Lymphangioleiomyomatosis (LAM) is a cystic lung disease frequently associated with reduced exercise capacity, mostly affecting young women. The disease is characterized by progressive pulmonary cystic change, recurrent pneumothorax, chylous pleural collections, and in most cases, progressive respiratory failure. Diagnosis is made by a combination of clinical features and computed tomography scanning or, with lung biopsy. We present a case report of a young woman who suspected of LAM and diagnosed with cystic lung disease, admitted to the intensive care unit in view of worsening hypoxia associated with pneumothorax. She was on ventilator support and placement of repeated intercostal drains and had a tracheostomy to step down to bilevel positive airway pressure support, after the medical stabilization. She was referred for pulmonary rehabilitation, in which she showed good outcomes and recovered well.


HTML PDF Share
  1. Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med 1999;160:628-33.
  2. McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, et al. Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: Lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med 2016;194:748-61.
  3. Baldi BG, Albuquerque AL, Pimenta SP, Salge JM, Kairalla RA, Carvalho CR. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2012;186:341-8.
  4. Araujo MS, Baldi BG, Freitas CS, Albuquerque AL, Marques da Silva CC, Kairalla RA, et al. Pulmonary rehabilitation in lymphangioleiomyomatosis: A controlled clinical trial. Eur Respir J 2016;47:1452-60.
  5. Gloeckl R, Nell C, Schneeberger T, Jaroschi I, Boensch M, Watz H, et al. Benefits of pulmonary rehabilitation in patients with severe lymphangioleiomyomatosis: Improving our practice: Novel approaches to pulmonary rehabilitation/poster discussion. Am J Respir Crit Care Med 2020;201:A6120.
  6. Gosselink R, Clerckx B, Robbeets C, Vanhullebusch T, Vanpee G, Segers J, et al. Physiotherapy in the intensive care unit. Neth J Crit Care. 2011;15:66-7.
  7. Palaniappan Ramanathan R, Chandrasekaran B. Reference equations for 6-min walk test in healthy Indian subjects (25-80 years). Lung India 2014;31:35-8.
  8. Chandrasekaran B, Ghosh A, Prasad C, Krishnan K, Chandrasharma B. Age and anthropometric traits predict handgrip strength in healthy normals. J Hand Microsurg 2010;2:58-61.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.